ABEO · Abeona Therapeutics Inc. · Webcasts, Transcripts & Audio
$4.45
+0.14 (+3.25%)
At close · Oct 27
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$255.33M
Shares
57.18M
Volume · Oct 27
663.68K
Avg daily vol (3M)
1.36M
Abeona Therapeutics Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Abeona Therapeutics Inc. (ABEO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-16
Abeona Therapeutics Inc. (ABEO) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-13
Abeona Therapeutics Inc. (ABEO) Q2 2026 Earnings Call
Revenue
$11.38M
▲ 2745% YoY Diluted EPS
$-0.35
▼ 120.5% YoY Gross margin
63.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Abeona Therapeutics Inc. (ABEO) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2026 Earnings Call Transcript
Confident tone
ZivaSkin Commercial Launch
Patient Demand and Referrals
QTC Activation and Expansion
Revenue
$8.72M
Diluted EPS
$-0.30
Gross margin
69.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call Transcript
Positive tone
ZivaSkin commercial launch execution
Qualified Treatment Center (QTC) expansion
Payer coverage and market access
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript
Positive tone
ZivaSkin commercial launch progress
Qualified treatment center (QTC) network expansion
Patient identification and demand
Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-02
Abeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call Transcript
Confident tone
ZEVASKYN FDA approval and commercial launch
Patient demand and QTC activation
Payer coverage and reimbursement
Revenue
$400,000
Diluted EPS
$1.71
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript
Confident tone
Patient demand and Abeona Assist
ZEVASKYN FDA approval and commercial launch
Qualified Treatment Centers and patient activation
Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Abeona Therapeutics Inc. (ABEO) Q4 2024 Earnings Call Transcript
Confident tone
Launch readiness and qualified treatment centers
pz-cel PDUFA and FDA approval
PRV (Priority Review Voucher)
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Abeona Therapeutics Inc. (ABEO) Q3 2024 Earnings Call
Diluted EPS
$-0.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Abeona Therapeutics Inc. (ABEO) Q2 2024 Earnings Call
Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Abeona Therapeutics Inc. (ABEO) Q1 2024 Earnings Call
Diluted EPS
$-1.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-18
Abeona Therapeutics Inc. (ABEO) Q4 2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Abeona Therapeutics Inc. (ABEO) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.48
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Abeona Therapeutics Inc. (ABEO) Q2 2023 Earnings Call Transcript
Revenue
$3.50M
▲ 250% YoY Diluted EPS
$-0.92
▼ 167.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Abeona Therapeutics Inc. (ABEO) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.54
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Abeona Therapeutics Inc. (ABEO) Q4 2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q2
2022-08-11
Abeona Therapeutics Inc. (ABEO) Q2 2022 Earnings Call Transcript
Revenue
$1.00M
Diluted EPS
$1.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-13
Abeona Therapeutics Inc. (ABEO) Q1 2022 Earnings Call Transcript
Revenue
$346,000
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-31
Abeona Therapeutics Inc. (ABEO) Q4 2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-15
Abeona Therapeutics Inc. (ABEO) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Abeona Therapeutics Inc. (ABEO) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-18
Abeona Therapeutics Inc. (ABEO) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-24
Abeona Therapeutics Inc. (ABEO) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Abeona Therapeutics Inc. (ABEO) Q3 2020 Earnings Call Transcript
Revenue
$7.00M
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Abeona Therapeutics Inc. (ABEO) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Abeona Therapeutics Inc. (ABEO) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-16
Abeona Therapeutics Inc. (ABEO) Q4 2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
318306
CUSIP
00289Y206
13F (30d)
15 filings
15 filers
Visit website
Investor relations